Patient and public involvement and engagement in the ASCEND PLUS trial: reflections from the design of a streamlined and decentralised clinical trial
Abstract Introduction ASCEND PLUS is a randomised controlled trial assessing the effects of oral semaglutide on the primary prevention of cardiovascular events in around 20,000 individuals with type 2 diabetes in the UK. The trial’s innovative design includes a decentralised direct-to-participant in...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2024-08-01
|
| Schriftenreihe: | Trials |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s13063-024-08393-2 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
